Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Coutte

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Urology Oncology|January 23, 2026
Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective StudyGarvey Mezepo, Zine-Eddine Khene, Jihane Boustani, et al.
JAMA Oncology|April 6, 2023
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical TrialKevin J Harrington, Robert L Ferris, Maura Gillison, et al.
Cancers|June 2, 2021
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown PrimaryYazan Abu-Shama, Julia Salleron, Florent Carsuzaa, et al.
The Lancet. Healthy Longevity|May 17, 2024
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trialJoël Guigay, Hervé Le Caer, François-Régis Ferrand, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort studyCarole Pflumio, Idriss Troussier, Xu Shan Sun, et al.
The Lancet. Oncology|August 8, 2020
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 studyXu-Shan Sun, Yungan Tao, Christophe Le Tourneau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2023
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trialYungan Tao, Xu-Shan Sun, Yoann Pointreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized TrialLionnel Geoffrois, Laurent Martin, Dominique De Raucourt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus InitiativeClémence Basse, Jonathan Khalifa, François Thillays, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2021
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensusFlorent Carsuzaa, Michel Lapeyre, Vincent Gregoire, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Urology Oncology|January 23, 2026
Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective StudyGarvey Mezepo, Zine-Eddine Khene, Jihane Boustani, et al.
JAMA Oncology|April 6, 2023
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical TrialKevin J Harrington, Robert L Ferris, Maura Gillison, et al.
Cancers|June 2, 2021
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown PrimaryYazan Abu-Shama, Julia Salleron, Florent Carsuzaa, et al.
The Lancet. Healthy Longevity|May 17, 2024
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trialJoël Guigay, Hervé Le Caer, François-Régis Ferrand, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort studyCarole Pflumio, Idriss Troussier, Xu Shan Sun, et al.
The Lancet. Oncology|August 8, 2020
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 studyXu-Shan Sun, Yungan Tao, Christophe Le Tourneau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2023
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trialYungan Tao, Xu-Shan Sun, Yoann Pointreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2018
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized TrialLionnel Geoffrois, Laurent Martin, Dominique De Raucourt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus InitiativeClémence Basse, Jonathan Khalifa, François Thillays, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2021
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensusFlorent Carsuzaa, Michel Lapeyre, Vincent Gregoire, et al.
Pageof 4